Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormone-sensitive early breast cancer: a case study

Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormone-sensitive early breast cancer: a case study

Jane Bryce1, Martina Bauer2, Peyman Hadji21National Cancer Institute, Naples, Italy; 2Philipps University of Marburg, Marburg, GermanyBackground: In order to reduce the risk of recurrence, adjuvant treatment with an aromatase inhibitor (AI) is recommended for postmenopausal women following surgery f...

Full description

Bibliographic Details
Main Authors:	Bryce J, Bauer M, Hadji P
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-03-01
Series:	Cancer Management and Research
Online Access:	http://www.dovepress.com/managing-arthralgia-in-a-postmenopausal-woman-taking-an-aromatase-inhi-a9602

Similar Items

Evaluation of Arthralgia Induced by Aromatase Inhibitor Therapy
by: Gulabi Mese, et al.
Published: (2013-02-01)

Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients
by: Jessica A. Martinez, et al.
Published: (2023-03-01)

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
by: Bauer M, et al.
Published: (2012-06-01)

Aromatase inhibitor-induced arthralgia: is vitamin D deficiency responsible?
by: Prieto-Alhambra, D, et al.
Published: (2011)

Aromatase inhibitor-induced arthralgia: Is vitamin D deficiency responsible?
by: Prieto-Alhambra, D, et al.
Published: (2011)

Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
by: Sally A.D. Romero, et al.
Published: (2020-02-01)

Acupuncture for Arthralgia Induced by Aromatase Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis
by: Xiaomeng Liu MD, et al.
Published: (2021-02-01)

Genetic determinants of aromatase inhibitor-related arthralgia: The B-ABLE cohort study
by: Garcia-Giralt, N, et al.
Published: (2013)

Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study.
by: Garcia-Giralt, N, et al.
Published: (2013)

A REGENERATIVE APPROACH TO AN ACUTE EXACERBATION OF HIP PAIN FROM AROMATASE INHIBITOR ASSOCIATED MUSCULOSKELETAL SYNDROME AND AROMATASE-INHIBITOR ARTHRALGIAS
by: Christian Vangeison, et al.
Published: (2022-10-01)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
by: Stefano Gonnelli, et al.
Published: (2008-12-01)

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers
by: Eugene F. Schuster, et al.
Published: (2023-07-01)

Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Rheumatic aspects of arthralgias associated with aromatase inhibitor therapy (analysis of a clinical case series)
by: A. D. Koltakova, et al.
Published: (2023-02-01)

Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer
by: Servitja, S, et al.
Published: (2012)

Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer.
by: Servitja, S, et al.
Published: (2012)

Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.
by: Gabriella Martino, et al.
Published: (2020-01-01)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
by: Junmei Cairns, et al.
Published: (2020-08-01)

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
by: Peyman Hadji, et al.
Published: (2017-06-01)

Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.
by: Nogues, X, et al.
Published: (2010)

The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia
by: Takahashi Masako, et al.
Published: (2011-10-01)

Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study
by: Xue Wang, et al.
Published: (2020-05-01)

Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: a protocol for a systematic review and network meta-analysis
by: Kyeore Bae, et al.
Published: (2020-05-01)

Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy
by: Rebecca Pedersini, et al.
Published: (2022-12-01)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
by: Swaathi Jayaraman, et al.
Published: (2020-05-01)

CORRIGENDUM to “Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study”
Published: (2020-08-01)

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
by: Butani D, et al.
Published: (2021-11-01)

The effect of exercise training on endothelial function in postmenopausal women with breast cancer under aromatase inhibitor therapy
by: Barbara Mayr, et al.
Published: (2022-12-01)

Health-related quality of life outcomes between non-steroid and steroid aromatase inhibitors and switching hormone therapy in postmenopausal women with ER+ breast cancer
by: Wawang Anwarudin, et al.
Published: (2024-12-01)

AROMATASE INHIBITORS IN BREAST CANCER THERAPY
by: Hande Karahan, et al.
Published: (2011-04-01)

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer
by: Sri Lakshmi Hyndavi Yeruva, et al.
Published: (2015-01-01)

Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment
by: Huda R. M. Rashdan, et al.
Published: (2022-01-01)

Aromatase inhibitor-induced arthralgia ameliorated by Mediterranean diet and active lifestyle guided by continuous glucose monitoring: a case report and review of the literature
by: Kalin L. Wilson, et al.
Published: (2024-02-01)

Aromatase Inhibitors Reduce the Expression of a Hypoxia Metagene in Oestrogen Receptor Positive Breast Cancer in Postmenopausal Women.
by: Ghazoui, Z, et al.
Published: (2009)

Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study
by: Alessandro Rossini, et al.
Published: (2020-01-01)

Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
by: Debora Cardoso, et al.
Published: (2020-02-01)

A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor–Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study
by: Sameh Gomaa, et al.
Published: (2022-06-01)

Effect of daily alcohol intake on sex hormone levels among postmenopausal breast cancer survivors on aromatase inhibitor therapy: a randomized controlled crossover pilot study
by: Elizabeth Mostofsky, et al.
Published: (2025-01-01)

Aromatase inhibitor strategies in metastatic breast cancer
by: Heather L McArthur, et al.
Published: (2009-07-01)